
Exogene
Exogene is an artificial intelligence company in Oxford, United Kingdom.
Eradicate cancer with next-generation immunotherapies
- Headquarters
- Oxford
- Business Model
- B2B
- Website
- exogene.co.uk
About
Exogene develops T-cell receptor-based medicines against solid tumors using generative AI and high-throughput laboratory screening. Its discovery platform searches for candidates against targets shared across patients and tumor types. Experimental validation through full-length TCR yeast display feeds data back into its models to improve prediction and design.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/exogene"><img src="https://indexed.vc/api/badge/company/exogene" alt="Exogene on Indexed.vc" width="260" height="76" /></a>
